Mehdi Mirsaeidi

Assistant Professor of Clinical

  • 2182 Citations
20042019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Mehdi Mirsaeidi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Tuberculosis Medicine & Life Sciences
Sarcoidosis Medicine & Life Sciences
Nontuberculous Mycobacteria Medicine & Life Sciences
Mycobacterium Medicine & Life Sciences
Iran Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Multidrug-Resistant Tuberculosis Medicine & Life Sciences
Lung Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

An update on IgG4-related lung disease

Morales, A. T., Cignarella, A. G., Jabeen, I. S., Barkin, J. S. & Mirsaeidi, M., Jan 1 2019, In : European Journal of Internal Medicine.

Research output: Contribution to journalReview article

Lung Diseases
Immunoglobulin G
Lymphomatoid Granulomatosis
Plasma Cell Granuloma
Antirheumatic Agents

Electronic cigarettes enhance replication of mycobacterium abscessus in airway epithelial cells

Korukonda, A., Zhang, C., Rodriguez, L., Guerrero, A., Campos, M. A., Holt, G., Fregien, N. L., Conner, G. E. & Mirsaeidi, M., Jun 1 2019, In : American journal of respiratory cell and molecular biology. 60, 6, p. 717-719 3 p.

Research output: Contribution to journalLetter

Mycobacterium
Tobacco Products
Epithelial Cells
Electronic Cigarettes
1 Citation (Scopus)

Growth Hormone-Releasing Hormone Receptor Antagonist Modulates Lung Inflammation and Fibrosis due to Bleomycin

Zhang, C., Cai, R., Lazerson, A., Delcroix, G., Wangpaichitr, M., Mirsaeidi, M., Griswold, A., Schally, A. V. & Jackson, R., Jan 1 2019, (Accepted/In press) In : Lung.

Research output: Contribution to journalArticle

Open Access
Hormone Antagonists
Bleomycin
Pneumonia
Fibrosis
Growth Hormone-Releasing Hormone

Guidelines-based treatment associated with improved economic outcomes in non-tuberculous mycobacterial lung disease

Marras, T. K., Mirsaeidi, M., Vinnard, C., Chan, E. D., Eagle, G., Zhang, R., Wang, P. & Zhang, Q., Jan 1 2019, In : Journal of Medical Economics.

Research output: Contribution to journalArticle

Open Access
Lung Diseases
Economics
Guidelines
Health Expenditures
Therapeutics

The unexplained increase of nontuberculous mycobacteriosis

Rivero-Lezcano, O. M., González-Cortés, C. & Mirsaeidi, M., Jan 1 2019, In : International Journal of Mycobacteriology. 8, 1, p. 1-6 6 p.

Research output: Contribution to journalReview article

Open Access
Nontuberculous Mycobacteria
Host-Pathogen Interactions
Incidence
Mycobacterium
Immunosuppressive Agents